Skip to content
← Back to this collection

PUBLICATIONS · 22689211

Complete morphologic and molecular remission after introduction of dasatinib in the treatment of a pediatric patient with t-cell acute lymphoblastic leukemia and ABL1 amplification.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Pediatr Blood Cancer
Publication date
2012 Aug
First author
Crombet O

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Crombet O
      type
      Author
    2. name
      Lastrapes K
      type
      Author
    3. name
      Zieske A
      type
      Author
    4. name
      Morales-Arias J
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Crombet O
      type
      Author
    2. name
      Lastrapes K
      type
      Author
    3. name
      Zieske A
      type
      Author
    4. name
      Morales-Arias J
      type
      Author
    bibliography ids
    1. nci-bib-571b226098289748858d0b5b
    book metadata
    content sha256
    3f16ab2dc62fffe82258727c09b4f057c83694167492c4b8d84b78e4217b62ff
    document type
    citation
    dois
    1. 10.1002/pbc.23327
    electronic publication date
    display
    2012 Jan 3
    precision
    day
    year
    2012
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:22689211
    immutable id
    pubmed:22689211@3f16ab2dc62fffe82258727c09b4f057c83694167492c4b8d84b78e4217b62ff
    journal
    abbreviation
    Pediatr Blood Cancer
    issn electronic
    1545-5017
    issn print
    1545-5009
    issue
    2
    name
    Pediatric blood & cancer
    nlm unique id
    101186624
    pages
    333-4
    volume
    59
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      22689211
      provenance
      batch id
      c95be1d0b8cf19942816
      provider
      NCBI PubMed ESummary
      record sha256
      bd52f895a9cbb7487b45c97c3644cfa449325fa5a143789c2b251204419f9158
      response sha256
      a96bb680a8f3690267e009557d1b07aab71455ba44aeba18695d98a3eeb5fcf2
      retrieved at
      2026-09-09T23:46:47.691937+00:00
      publication date
      display
      2012 Aug
      precision
      month
      year
      2012
      publication types
      1. Case Reports
      2. Journal Article
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/22689211/
      title
      Complete morphologic and molecular remission after introduction of dasatinib in the treatment of a pediatric patient with t-cell acute lymphoblastic leukemia and ABL1 amplification.

      Preserved source evidence · Independent clinical review pending · Not medical advice